Drug interactions are actually the greatest impediment in managing HIV/HCV co-contaminated clients. In terms of security results, tenofovir DF used with ledipasvir or velpatasvir can lead to an increase in serum creatinine, particularly when combined with a pharmacokinetic booster. [139] The use of tenofovir DF really should be prevented in these s… Read More